Precision Biosciences (DTIL) Profit After Tax (2018 - 2025)
Historic Profit After Tax for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$21.8 million.
- Precision Biosciences' Profit After Tax fell 3255.4% to -$21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.6 million, marking a year-over-year decrease of 106952.34%. This contributed to the annual value of $7.2 million for FY2024, which is 11168.81% up from last year.
- Per Precision Biosciences' latest filing, its Profit After Tax stood at -$21.8 million for Q3 2025, which was down 3255.4% from -$23.5 million recorded in Q2 2025.
- Over the past 5 years, Precision Biosciences' Profit After Tax peaked at $32.7 million during Q2 2024, and registered a low of -$31.0 million during Q2 2022.
- In the last 5 years, Precision Biosciences' Profit After Tax had a median value of -$18.7 million in 2021 and averaged -$14.0 million.
- As far as peak fluctuations go, Precision Biosciences' Profit After Tax soared by 37541.0% in 2024, and later tumbled by 33946.2% in 2025.
- Quarter analysis of 5 years shows Precision Biosciences' Profit After Tax stood at -$22.3 million in 2021, then decreased by 27.81% to -$28.5 million in 2022, then skyrocketed by 42.82% to -$16.3 million in 2023, then decreased by 8.94% to -$17.7 million in 2024, then dropped by 22.69% to -$21.8 million in 2025.
- Its Profit After Tax stands at -$21.8 million for Q3 2025, versus -$23.5 million for Q2 2025 and -$20.6 million for Q1 2025.